ACE2 and COVID-19: The main findings of this study emphasize the necessity of early assessment and monitoring of cardiac injury and coagulation markers in COVID-19 patients, the role of ACE2 in viral invasion, and the potential benefits of renin–angiotensin–aldosterone system inhibitors.